Beyond rash management with amivantamab-lazertinib for EGFR-mutated non-small cell lung cancer: the unresolved challenge...
Editorial Commentary
Beyond rash management with amivantamab-lazertinib for EGFR-mutated non-small cell lung cancer: the unresolved challenge of paronychia in the COCOON trial